for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Vertex cystic fibrosis treatment gets U.S. approval for use in 6-11 year olds

June 9 (Reuters) - Vertex Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its cocktail therapy, Trikafta, to treat cystic fibrosis in children aged aged 6 to 11. (Reporting by Dania Nadeem in Bengaluru; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up